GlassScriptPhysician profile
Khoa D Tran
NPI 1437335239
$1,359.89
in general payments reported to CMS, 2019-2025
13 companies · $128 in 2025
The $128 reported for 2025 was less than what a typical Pediatric Gastroenterology provider received nationally (typical 2025 total: $195).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $152 · 2020: $82.64 · 2021: $92.81 · 2022: $26.27 · 2023: $380 · 2024: $498 · 2025: $128.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $973 · Education: $32.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $973.23 |
| Education | $32.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $312.80 | 2022-2025 | |
| Abbvie INC. | $309.09 | 2019-2024 | |
| Stryker Corporation | $232.91 | 2023-2024 | Mako, Hoffmann, Gamma |
| Qol Medical, LLC | $138.67 | 2023-2024 | Sucraid, Sucraid |
| Orthofix Medical, INC. | $88.17 | 2023 | Spinal-Stim, Physio-Stim |
| Mayne Pharma Commercial LLC | $83.20 | 2019 | |
| Organon LLC | $48.99 | 2023-2024 | Hadlima |
| Pfizer INC. | $44.50 | 2021 | |
| Celltrion USA INC. | $32.84 | 2024 | Zymfentra |
| Takeda Pharmaceuticals U.S.A., INC. | $26.16 | 2024 | Eohilia |
| Nestle Healthcare Nutrition INC. | $21.00 | 2023 | |
| Ipsen Biopharmaceuticals, INC | $20.73 | 2024 | Iqirvo |
| Travere Therapeutics, INC. | $0.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Khoa Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.